These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2274099)

  • 1. Correlation between carbohydrate and catecholamine level impairments in methionine sulfoximine epileptogenic rat brain.
    Hevor TK; Aissi E; Delorme P
    Neurochem Res; 1990 Sep; 15(9):861-8. PubMed ID: 2274099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of indolamines in the glycogenic effect of the convulsant methionine sulfoximine in rat brain.
    Hevor TK; Delorme P
    Experientia; 1990 Jul; 46(7):710-3. PubMed ID: 1695579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between brain glycogen and convulsive state in mice submitted to methionine sulfoximine.
    Bernard-Helary K; Lapouble E; Ardourel M; Hévor T; Cloix JF
    Life Sci; 2000 Aug; 67(14):1773-81. PubMed ID: 11021361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and ultrastructural study of glycogen in cultured astrocytes submitted to the convulsant methionine sulfoximine.
    Hevor TK; Delorme P
    Glia; 1991; 4(1):64-9. PubMed ID: 1646766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic neurotransmission plays a major role in the action of the glycogenic convulsant methionine sulfoximine.
    Picard M; Cloix JF; Hevor TK
    Neurosci Res; 2011 Jul; 70(3):313-20. PubMed ID: 21396968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine sulfoximine increases acetylcholine level in the rat brain: no relation with epileptogenesis.
    Richard O; Hevor T
    Neuroreport; 1995 Oct; 6(15):2027-32. PubMed ID: 8580433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain glycogen and neurotransmitter levels in fast and slow methionine sulfoximine-selected mice.
    Cloix JF; Tahi Z; Boissonnet A; Hévor T
    Exp Neurol; 2010 Oct; 225(2):274-83. PubMed ID: 20547153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen particles in methionine sulfoximine epileptogenic rodent brain and liver after the administration of methionine and actinomycin D.
    Delorme P; Hevor TK
    Neuropathol Appl Neurobiol; 1985; 11(2):117-28. PubMed ID: 4022258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The xenobiotic methionine sulfoximine modulates carbohydrate anabolism and related genes expression in rodent brain.
    Hélary-Bernard K; Ardourel MY; Cloix JF; Hevor T
    Toxicology; 2000 Nov; 153(1-3):179-87. PubMed ID: 11090956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilepsy, regulation of brain energy metabolism and neurotransmission.
    Cloix JF; Hévor T
    Curr Med Chem; 2009; 16(7):841-53. PubMed ID: 19275597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro glycogenic effects of methionine sulfoximine are different in two inbred strains of mice.
    Bernard-Hélary K; Ardourel MY; Hévor T; Cloix JF
    Brain Res; 2002 Mar; 929(2):147-55. PubMed ID: 11864619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen content and fructose-1, 6-biphosphatase activity in methionine sulfoximine epileptogenic mouse brain and liver after protein synthesis inhibition.
    Hevor TK; Delorme P; Gayet J
    Neuropathol Appl Neurobiol; 1985; 11(2):129-39. PubMed ID: 2991793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthesis and immunocytochemical study of fructose-1,6-biphosphatase in methionine sulfoximine epileptogenic rodent brain.
    Hevor TK; Delorme P; Beauvillain JC
    J Cereb Blood Flow Metab; 1986 Jun; 6(3):292-7. PubMed ID: 3011827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of L-methionine-S-sulfoximine as the convulsant isomer of methionine sulfoximine.
    Rowe WB; Meister A
    Proc Natl Acad Sci U S A; 1970 Jun; 66(2):500-6. PubMed ID: 4393740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of 5-hydroxytryptamine in the methionine sulfoximine epileptogenic rat brain.
    Sellinger OZ; Dietz DD
    J Pharmacol Exp Ther; 1981 Jan; 216(1):77-82. PubMed ID: 6161244
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition by metyrapone of convulsions and storage of brain glycogen in mice induced by methionine sulfoximine (MSO).
    Berel A; Lehr PR; Gayet J
    Brain Res; 1977 Jun; 128(1):193-6. PubMed ID: 871909
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the convulsant methionine sulfoximine on striatal dopamine metabolism.
    Rothstein JD; Tabakoff B
    J Neurochem; 1982 Aug; 39(2):452-7. PubMed ID: 6123558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
    Ho AK; Smith JA
    Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the hypothermia induced by methionine sulfoximine in the rat.
    Ginefri-Gayet M; Gayet J
    Pharmacol Biochem Behav; 1988 Dec; 31(4):797-802. PubMed ID: 3252271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconvulsive changes in brain glucose metabolism following drugs inhibiting glutamate decarboxylase.
    Horton RW; Meldrum BS
    J Neurochem; 1976 Apr; 26(4):805-9. PubMed ID: 965969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.